Trevi Therapeutics, Inc. ($TRVI)
Filing Information
| Accession Number | 0001193125-26-394456 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 17, 2026 |
| Document | View SEC Filing |
Transactions
8
Total Shares
118,419
Total Value
$721,908.57
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Sep 15, 2026 | Exercise/Conversion | 18,421 | $3.04 | $55,999.84 | 24,772 | Direct | โ | View Details | |
Director | Common Stock | โ | Sep 15, 2026 | Sale | 18,321 | $15.09 | $276,463.89 | 6,451 | Direct | โ | View Details | |
Director | Common Stock | โ | Sep 15, 2026 | Sale | 100 | $15.88 | $1,588.00 | 6,351 | Direct | โ | View Details | |
Director | Common Stock | โ | Sep 15, 2026 | Exercise/Conversion | 21,052 | $3.33 | $70,103.16 | 27,403 | Direct | โ | View Details | |
Director | Common Stock | โ | Sep 15, 2026 | Sale | 20,952 | $15.09 | $316,165.68 | 6,451 | Direct | โ | View Details | |
Director | Common Stock | โ | Sep 15, 2026 | Sale | 100 | $15.88 | $1,588.00 | 6,351 | Direct | โ | View Details | |
Director | Stock Option (right to buy) | Derivative | Sep 15, 2026 | Exercise/Conversion | 18,421 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
Director | Stock Option (right to buy) | Derivative | Sep 15, 2026 | Exercise/Conversion | 21,052 | $0.00 | $0.00 | 0 | Direct | โ | View Details |